General Information of the Compound
Compound ID
CP0011970
Compound Name
8-(3-chlorophenyl)-1-(oxan-4-yl)-[1,2,4]triazolo[4,3-a]quinoxaline
    Show/Hide
Formula
C20H17ClN4O
Molecular Weight
364.836
Canonical SMILES
Clc1cccc(c1)-c1ccc2ncc3nnc(C4CCOCC4)n3c2c1
    Show/Hide
InChI
InChI=1S/C20H17ClN4O/c21-16-3-1-2-14(10-16)15-4-5-17-18(11-15)25-19(12-22-17)23-24-20(25)13-6-8-26-9-7-13/h1-5,10-13H,6-9H2
    Show/Hide
InChIKey
ZEXGCBYCYMHFPR-UHFFFAOYSA-N
Physicochemical Property
logP
4.4919
Rotatable Bonds
2
Heavy Atom Count
26
Polar Areas
52.31
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
ChEMBL ID
CHEMBL4862738
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01902, Serine-protein kinase ATM
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000154 HEK293-EBNA1-6E Homo sapiens (Human)  1
1
IC50 = 1400 nM
   TI
   LI
   LO
   TS